Correlation Between CytomX Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on CytomX Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Lyra Therapeutics.
Diversification Opportunities for CytomX Therapeutics and Lyra Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CytomX and Lyra is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 1.95 times more return on investment than Lyra Therapeutics. However, CytomX Therapeutics is 1.95 times more volatile than Lyra Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 135.00 in CytomX Therapeutics on August 24, 2024 and sell it today you would lose (46.42) from holding CytomX Therapeutics or give up 34.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Lyra Therapeutics
Performance |
| Timeline |
| CytomX Therapeutics |
| Lyra Therapeutics |
CytomX Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite CytomX Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| CytomX Therapeutics vs. Lyra Therapeutics | CytomX Therapeutics vs. Hookipa Pharma | CytomX Therapeutics vs. Cingulate Warrants | CytomX Therapeutics vs. SAB Biotherapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |